IGM Biosciences Inc Cash Flow Quality Index

Latest as of June 2025: -0.52x

IGM Biosciences Inc cash flow quality index. IGM Biosciences Inc (IGMS) has a Cash Flow Quality Index of -0.52x as of June 2025. Operating cash flow of $-50.79 Million is below net income of $97.58 Million, suggesting accrual-heavy earnings not yet converted to cash. See IGM Biosciences Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.52x

Operating CF / Net Income

Operating Cash Flow

$-50.79 Million

USD

Net Income

$97.58 Million

USD

Data as of

Jun 2025

Most recent filing

IGM Biosciences Inc Cash Flow Quality Index by Year (None–None)

IGM Biosciences Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for IGM Biosciences Inc. For the full cash flow conversion analysis, see IGMS cash flow metrics.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.